About Us
About Us
What we stand for
Governance
External Advisory Board
Porto.CCC
Transversal Units
Our Heritage
Contacts
Research
Integrative Programs
Research Groups
Publications
Scientific Platforms
Responsible Research
Events
Seminars
Upcoming Events
Events Archive
Education
Advanced Training
Post-Graduations
i3S Community
About our Community
Postdoc Representatives
PhD Student Representatives
Postgraduate Student Ombudsperson
People
Knowledge Translation
Clinical Initiatives
Innovation and Valorization
Science in Society
Jobs & Internships
Job Opportunities
Academic Internships
Legal & Funding
Status & Reports
Core Funding
R&D Projects
Procurement
Transparency
News
PT
creating a
healthier future
DONATE NOW
SUPPORT SCIENCE
News
26.07.16
i3S discovers how stomach cancer “persuades” fat tissue to feed it
Discovery paves the way for the development of therapies capable of blocking the exchange of signals between tumour cells and adipose tissue cells.
26.07.09
i3S study paves the way towards delaying immune system ageing
Scientists identify key proteins that preserve thymus function and T-cell production.
26.07.02
i3S study validates strategy for developing vaccines against colorectal cancer
Research identifies persistent vulnerabilities in colorectal tumours and lays the groundwork for the development of personalised immunotherapies.
26.07.02
i3S researcher honoured by the European Society of Human Genetics
Bibiana Ribeiro received the ELPAG Early Career Award for the best oral presentation on the ethical, legal, and psychosocial aspects of genetics.
26.07.01
i3S scientist wins grant for three presentations at European congress
For scientist Rita Araújo, taking part in ECP 2026 reinforces the role of pathology as a bridge between research and clinical practice.
26.07.01
i3S inaugurates garden in memory of researcher Raquel Seruca
An evening gathering brought together the i3S community, family members, and guests to mark the inauguration of the Raquel Seruca Garden, on the day she would have turned 64.
26.07.01
i3S leads project to develop ultrasound-activated nanomedicines for the treatment of glioblastoma
The project received 150,000 euros in funding under the 2025 Exploratory Projects Call of the UT Austin Portugal Programme.
26.06.26
i3S discovers treatment that enhances chemotherapy against acute myeloid leukaemia
New therapeutic strategy that enhances chemotherapy against acute myeloid leukaemia to be tested in collaboration with IPO Porto.
26.06.25
i3S launches national survey on genetic screening before pregnancy
The project aims to understand the views of people living in Portugal on preconception genetic carrier screening and support the development of a genetic counselling programme tailored to the national context.
Subscribe to our newsletter and keep up to date with our latest achievements.
Newsletter Subscription
Archive